Good Afternoon!
Hey, everyone. It's Adam from Elite Trade Club. Here’s what moved the market today.
Big policy shifts often lead to big market winners. A new investor report reveals 6 stocks positioned to benefit most under the current administration.
These companies could be at the center of capital flows, regulation tailwinds, and sector expansion.
Past picks from this strategy have shown potential for triple-digit gains.
[Download the Report Free]
(By submitting your email, you’ll also get a free Profit from the Pros membership, which highlights exclusive market updates and daily Strong Buy stocks. You can unsubscribe at any time.)
U.S. equities were mixed on Thursday for the second day in a row, but the S&P 500 continued its recovery thanks to Cisco gains and tariff deal optimism.
|
|
Phillips 66 (NYSE: PSX) has agreed to sell 65% of its retail marketing business in Germany and Austria to a consortium backed by Energy Equation Partners and Stonepeak.
The deal values the business at roughly $2.8 billion and is expected to close in the second half of 2025, pending regulatory approval.
This transaction includes 970 fuel stations, 843 of which are JET-branded. Phillips 66 will retain a 35% non-operated interest through a new joint venture structure. The company will also continue to supply fuel to the network under a long-term agreement from the MiRO refinery.
For shareholders, this move signals Phillips 66’s ongoing focus on simplifying its portfolio and returning value to investors.
The company expects about $1.6 billion in pre-tax cash proceeds, which it plans to use for debt reduction and shareholder returns.
This adds financial flexibility at a time when downstream operators are emphasizing capital discipline and efficiency over asset ownership in lower-margin regions.
The deal marks a significant shift in how Phillips 66 manages its European retail footprint while maintaining a supply relationship that supports refinery utilization. The transaction aligns with broader industry trends of asset-light models and cash redeployment.
Imagine knowing the historic win rate of a trade before placing it—70%, 80%, even 90%+.
These FIVE Candlestick Pattern Cheatsheets reveal high-probability setups and help identify precise entry and exit points.
Backtested and simplified for real-world trading, these tools are designed to reduce emotion and increase confidence.
They’re now available for free, while supplies last.
[Claim Your Free Candlestick Cheatsheets]
*The profits and performance shown are not typical and you may lose money. We make no future earnings claims. All trades expressed are from historical, backtested data in order to demonstrate the potential of the system.
Netflix (NASDAQ: NFLX) says its ad-supported plan has reached 94 million monthly active users, growing by over 20 million since November.
The $7.99-per-month tier is now one of the fastest-growing parts of Netflix’s business and is aimed at viewers who want to save money in exchange for watching ads.
The company says this plan reaches more 18–34-year-olds than any U.S. cable or broadcast network. That matters because this is the age group advertisers often care about most. As more people move away from traditional TV, Netflix appears to be capturing younger viewers at scale.
For investors, this signals Netflix is gaining real traction with a product that expands its audience and builds a new revenue stream.
We think the strong growth proves Netflix can make money from users even if they don’t pay for the higher-priced ad-free plans. That’s important as competition rises and pricing power flattens.
The ad business also gives Netflix more ways to grow without relying only on subscriber numbers. It may help reduce churn and boost profits, especially as the platform expands its global advertising efforts.
This update confirms Netflix is turning engagement into income, something Wall Street watches closely.
AI’s capabilities are growing rapidly—handling layered conversations, correcting itself, and adapting in real time.
This shift is opening up new frontiers for early investors.
A free report just revealed 5 high-potential stocks—including one under-the-radar name with breakout potential.
These tickers are positioned to ride the AI boom in its most advanced form yet.
[See the Top 5 AI Stocks – Free Access]
(By submitting your email address, you will receive a free subscription to the Profit From The Pros e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time.)
Pfizer (NYSE: PFE) is raising $2.2 billion through a European bond sale, marking its first euro-denominated debt deal since 2017. The offering includes multiple maturities ranging from four to twenty years, giving the company long-term access to cheaper funding overseas.
The deal comes as more U.S. companies turn to European credit markets to take advantage of lower interest rates. So far this year, U.S. firms have issued a record amount of euro bonds, and Pfizer is now part of that wave. The bonds are being issued by a Dutch finance arm and fully backed by Pfizer Inc.
For investors, this move gives Pfizer added flexibility to manage debt, invest in R&D, and maintain dividend strength without putting pressure on its U.S. balance sheet.
Tapping European markets at this scale signals that Pfizer is positioning itself to keep costs low while still funding global operations and shareholder priorities.
This kind of cross-border financing can also shield the company from currency risk and improve access to international capital pools.
As global borrowing conditions shift, Pfizer’s ability to lock in longer-term rates abroad may help smooth out financing costs ahead of any U.S. rate volatility. For long-term holders, it reinforces the company’s balanced and forward-looking financial strategy.
Foot Locker Inc [FL] $23.92 (+85.86 %)
Foot Locker was Thursday’s biggest winner, as Dick’s Sporting Goods announced a $2.4 billion acquisition offer, representing a nearly 90% premium to its Wednesday close.
DigitalBridge Group Inc [DBRG] $11.85 (+24.61%)
DigitalBridge stock jumped after fresh reports suggested that 26North Partners and Mercuria were in advanced talks to acquire the company.
Journey Medical Corp [DERM] $7.10 (+18.93%)
Journey Medical rose after posting a lower-than-expected Q1 loss and beating revenue forecasts by more than 10%.
Biohaven Ltd [BHVN] $15.81 (-19.58%)
Biohaven shares plunged today after the FDA unexpectedly delayed its review of the company’s rare-disease drug troriluzole and announced plans for an advisory committee meeting.
Fiserv Inc [FI] $159.13 (-16.19%)
Fiserv stock fell after management projected continued weak growth for its Clover unit, missing investor expectations.
Dick's Sporting Goods Inc [DKS] $179.02 (-14.59%)
Dick’s Sporting Goods drove FL’s price to YTD highs, but saw its own stock nosedive following the $2.4 billion deal announcement, as investors were concerned about dilution and debt.
Policy changes often spark market moves—and this latest investor report pinpoints 6 stocks aligned with current trends in Washington.
These companies could benefit from targeted spending, sector incentives, and regulatory tailwinds.
Previous picks from this strategy have surged triple digits. Now could be the time to act.
[Access the 6 Stock Picks Now]
(By submitting your email, you’ll also get a free Profit from the Pros membership, which highlights exclusive market updates and daily Strong Buy stocks. You can unsubscribe at any time.)
That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!
Thanks for reading. I'll see you at the next open!
Best Regards,
— Adam G.
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails.